Skip to main content

Want a detailed portfolio tracker?

Vaxart (VXRT) P/E (2018 - 2026)

Vaxart (VXRT) P/E from Feb 12, 2018 to Jul 21, 2026. The TTM Vaxart (VXRT) P/E is 3.37. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Vaxart (VXRT)

YearP/EChange
20263.37-42.06%
20255.82-385.72%
2024-2.04+122.64%
2023-0.91-21.41%
2022-1.16-89.38%
2021-10.95-40.35%
2020-18.36+3904.33%
2019-0.46-89.50%
2018-4.37N/A

Comparison Vaxart (VXRT) P/E with competitors

Vaxart (VXRT) P/E is 3.37.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.95%
NBYStablecoin Development Corp0.00-99.87%
ENLVEnlivex Ltd0.07-97.78%
FGENFibroGen Inc0.24-92.88%
CHRSCoherus Biosciences Inc0.85-74.82%
FBIOFortress Biotech Inc0.95-71.84%
ORMPOramed Pharmaceuticals Inc1.50-55.40%
AGENAgenus Inc3.01-10.69%
INVAInnoviva Inc3.15-6.41%
CRMDCorMedix Inc3.63+7.67%
CVACCureVac N.V.4.45+31.92%
GLPGGalapagos NV4.86+44.18%
SRPTSarepta Therapeutics Inc4.88+44.87%
ABEOAbeona Therapeutics Inc5.39+59.87%
ABUSArbutus Biopharma Corp5.60+66.04%
ZVRAZevra Therapeutics Inc5.89+74.70%
SPROSpero Therapeutics Inc6.23+84.82%
CGENCompugen Ltd6.31+87.36%
RIGLRigel Pharmaceuticals6.87+103.92%
SLXNSilexion Therapeutics Corp7.30+116.50%
OMEROmeros Corporation9.26+174.74%
AUPHAurinia Pharmaceuticals Inc9.58+184.42%
PLXProtalix BioTherapeutics Inc10.89+223.18%
ACADAcadia Pharmaceuticals Inc11.73+248.03%
TBPHTheravance Biopharma Inc12.26+263.86%
ADMAAdma Biologics Inc12.42+268.49%
HRMYHarmony Biosciences Holdings Inc13.82+310.10%
SABSSAB Biotherapeutics Inc14.14+319.48%
NAGENiagen Bioscience Inc14.82+339.71%
INCYIncyte Corp15.82+369.52%
REGNRegeneron Pharmaceuticals Inc15.86+370.53%
PBYIPuma Biotechnology Inc17.32+413.82%
CPRXCatalyst Pharmaceuticals Inc17.44+417.49%
EXELExelixis Inc17.54+420.42%
TGTXTG Therapeutics Inc18.97+462.80%
MDXGMimedx Group Inc20.55+509.87%
XOMAXOMA Royalty Corp22.87+578.80%
ARGXArgen X SE24.30+621.04%
CTMXCytomX Therapeutics Inc24.82+636.56%
XOMAOXOMA Royalty Corp25.34+652.10%
HALOHalozyme Therapeutics Inc25.62+660.38%
XOMAPXOMA Royalty Corp25.67+661.75%
VRTXVertex Pharmaceuticals Inc27.99+730.73%
RPRXRoyalty Pharma plc - Class A28.69+751.29%
SLNOSoleno Therapeutics Inc29.02+761.02%
ASNDAscendis Pharma A/S30.09+792.78%
LGNDLigand Pharmaceuticals Inc - Class B37.91+1025.03%
APLSApellis Pharmaceuticals Inc39.02+1057.94%
BMRNBiomarin Pharmaceutical Inc42.21+1152.62%
KRYSKrystal Biotech Inc45.34+1245.55%
ONCBeiGene Ltd69.54+1963.59%
PHARPharming Group N.V.75.03+2126.36%
TECHBio-Techne Corp101.96+2925.58%
VCELVericel Corp109.92+3161.88%
ALNYAlnylam Pharmaceuticals Inc117.96+3400.58%
GMABGenmab140.29+4063.09%
TLXTelix Pharmaceuticals Ltd162.15+4711.84%
CORTCorcept Therapeutics Inc212.86+6216.48%